Stay updated on Safety of HSC835 in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.

Latest updates to the Safety of HSC835 in Hematological Malignancies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. This update appears to be a version patch with no impact on study details or page content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded three disease terms—Burkitt lymphoma, B-cell chronic lymphocytic leukemia, and acute lymphoid leukemia—to the study's keywords/MeSH terms to broaden indexing and searchability.SummaryDifference0.2%

- Check41 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision label updated to v3.4.2 and the previous notices about funding and operating status were removed. These changes are minor and do not affect study details or access to information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operating status, with guidance to visit cc.nih.gov and opm.gov for updates. Updated the system revision from Revision: v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Safety of HSC835 in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.